Skip to main content
. 2021 May 6;11:9682. doi: 10.1038/s41598-021-88809-0

Figure 2.

Figure 2

Characterization of anti-SARS-COV-2 antibodies as supernatants from hybridoma clones. (a) Antigen specificity of antibody binding from IgG-secreting hybridomas chosen from Series 1–3 immunization schedules. Numbers inside circles are total clones selected, numbers within each portion reflect binding selectivity. (b) Distribution of affinities of the 33 selected clones as measured by BLI. (c) Binding to two different Spike recombinant proteins (ecto Spike trimer and S1 polypeptide) as determined by ELISA. (d) Binding of antibodies to γ-irradiated WA-SARS-CoV-2 by ELISA (15 ng/mL virus plated, supernatant undiluted, secondary antibody = goat anti-mouse IgG HRP conjugate).